Liver Cirrhosis
📧 Sign up to get email alerts when something new happens for Liver Cirrhosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: Administration of Probiotics in Cirrhotic Patients Listed for Liver Transplantation [NA]
This document reports a completed clinical trial evaluating the administration of probiotics in patients with liver cirrhosis who are listed…
-
CLINICAL_TRIALS trial_result · 2016-06-29Clinical Trial Update: A Study to Evaluate Chronic Hepatitis C Virus (HCV) Infection in Cirrhotic Adults With Genotype 1b (GT1b) Infection [Phase 3]
Phase 3 trial in cirrhotic adults with genotype 1b chronic hepatitis C infection has completed and results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: Abdominal Hernia in Cirrhotic Patients: Surgery or Conservative Treatment? [NA]
A completed clinical trial from University of Sao Paulo General Hospital compares surgical versus conservative treatment for abdominal herni…
-
CLINICAL_TRIALS trial_result · 2016-06-08Clinical Trial Update: Fructans, Lactitol and Lactose in Minimal Hepatic Encephalopathy [NA]
A clinical trial evaluating fructans, lactitol, and lactose for minimal hepatic encephalopathy in patients with liver cirrhosis has complete…
-
CLINICAL_TRIALS trial_result · 2016-06-08Clinical Trial Update: Renal Function Determination in Patients With Liver Cirrhosis
This clinical trial update notes that the study evaluating renal function determination in patients with liver cirrhosis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS) [Phase 3]
The Phase 3 CATS trial evaluating satavaptan for ascites due to liver cirrhosis has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver [Phase 3]
Phase 3 trial of satavaptan to prevent recurrence of ascites in patients with cirrhosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver [Phase 3]
A Phase 3 trial of satavaptan for preventing recurrence of ascites in patients with ascites due to liver cirrhosis was terminated.
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF [Phase 2]
Phase 2 pharmacokinetic and pharmacodynamic study of IDN-6556 in acute liver failure conditions was terminated, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation [Phase 1]
Phase 1 safety study of liver natural killer (NK) cell therapy in patients undergoing liver transplantation for hepatocellular carcinoma; re…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Terlipressin in Septic Shock in Cirrhosis [Phase 2, Phase 3]
Clinical trial update indicates completion of Phase 2 and Phase 3 studies evaluating terlipressin for septic shock in patients with liver ci…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time Measurement [NA]
A completed clinical trial evaluated continuous reaction-time measurement as a diagnostic tool for covert/minimal hepatic encephalopathy in …
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Mesenchymal Stem Cells Treat Liver Cirrhosis [Phase 1, Phase 2]
A Phase 1/Phase 2 trial of mesenchymal stem cells for liver cirrhosis is currently suspended.
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosis [Phase 4]
Phase 4 trial update evaluating intestinal decontamination with rifaximin in patients with liver cirrhosis and ascites, focusing on inflamma…
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: Monitoring of Encephalopathy in Cirrhotic Patients Admitted in Intensive Care
This clinical trial update shows that the study examining monitoring of hepatic encephalopathy in cirrhotic patients admitted to intensive c…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Norfloxacin Therapy for Patients With Cirrhosis and Severe Liver Failure [Phase 3]
Phase 3 trial evaluating norfloxacin for patients with cirrhosis and severe liver failure was terminated.
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis [Phase 4]
This document provides a Phase 4 clinical trial update evaluating the effect of anticoagulation after endoscopic therapy in patients with ci…
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: Human Fetal Liver Cell Transplantation in Chronic Liver Failure [Phase 1, Phase 2]
Clinical trial update reporting the completion of Phase 1 and Phase 2 studies of human fetal liver cell transplantation for chronic liver fa…
-
CLINICAL_TRIALS trial_result · 2015-09-30Clinical Trial Update: A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy [Phase 2]
A Phase 2 study evaluating the safety and efficacy of HPN-100 in subjects with liver cirrhosis and episodic hepatic encephalopathy has compl…
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Liver Regeneration Therapy by Intrahepatic Arterial Administration of Autologous Adipose Tissue Derived Stromal Cells [NA]
A clinical trial evaluating intrahepatic arterial administration of autologous adipose tissue-derived stromal cells for liver cirrhosis has …
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis [Phase 1]
Open-label Phase I single-dose pharmacokinetics and safety study of BI 201335 in patients with compensated liver cirrhosis and Hepatitis C; …
-
CLINICAL_TRIALS trial_result · 2015-07-29Clinical Trial Update: Thoracoscopic Mesh Repair of Diaphragmatic Defects for Hepatic Hydrothorax [NA]
The clinical trial evaluating thoracoscopic mesh repair of diaphragmatic defects for hepatic hydrothorax in patients with liver cirrhosis ha…
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Prevalence and Predictive Factors of Portal Vein Thrombosis in Patients With Cirrhosis
This clinical trial update reports on how prevalent portal vein thrombosis is among patients with liver cirrhosis and identifies factors tha…
-
CLINICAL_TRIALS trial_result · 2015-07-01Clinical Trial Update: Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver [Phase 2]
Phase 2 trial evaluating yttrium-90 radioembolization before surgical resection or radiofrequency ablation for hepatocellular carcinoma in c…
-
CLINICAL_TRIALS trial_result · 2015-06-12Clinical Trial Update: Metformin Experience on Minimal Hepatic Encephalopathy [Phase 4]
A Phase 4 clinical trial evaluating metformin for minimal hepatic encephalopathy in liver cirrhosis; the current status is unknown.